BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 37954086)

  • 1. Exploring the cell-free total RNA transcriptome in diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma patients as biomarker source in blood plasma liquid biopsies.
    Decruyenaere P; Giuili E; Verniers K; Anckaert J; De Grove K; Van der Linden M; Deeren D; Van Dorpe J; Offner F; Vandesompele J
    Front Oncol; 2023; 13():1221471. PubMed ID: 37954086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-of-Origin Subtyping of Diffuse Large B-Cell Lymphoma by Using a qPCR-based Gene Expression Assay on Formalin-Fixed Paraffin-Embedded Tissues.
    Yan WH; Jiang XN; Wang WG; Sun YF; Wo YX; Luo ZZ; Xu QH; Zhou XY; Cao JN; Hong XN; Li XQ
    Front Oncol; 2020; 10():803. PubMed ID: 32582543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group.
    Staiger AM; Ziepert M; Horn H; Scott DW; Barth TFE; Bernd HW; Feller AC; Klapper W; Szczepanowski M; Hummel M; Stein H; Lenze D; Hansmann ML; Hartmann S; Möller P; Cogliatti S; Lenz G; Trümper L; Löffler M; Schmitz N; Pfreundschuh M; Rosenwald A; Ott G;
    J Clin Oncol; 2017 Aug; 35(22):2515-2526. PubMed ID: 28525305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies.
    Scott DW; Mottok A; Ennishi D; Wright GW; Farinha P; Ben-Neriah S; Kridel R; Barry GS; Hother C; Abrisqueta P; Boyle M; Meissner B; Telenius A; Savage KJ; Sehn LH; Slack GW; Steidl C; Staudt LM; Connors JM; Rimsza LM; Gascoyne RD
    J Clin Oncol; 2015 Sep; 33(26):2848-56. PubMed ID: 26240231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-cell phenotypic profiling to identify a set of immune cell protein biomarkers for relapsed and refractory diffuse large B cell lymphoma: A single-center study.
    Shi Y; Ding W; Gu W; Shen Y; Li H; Zheng Z; Zheng X; Liu Y; Ling Y
    J Leukoc Biol; 2022 Dec; 112(6):1633-1648. PubMed ID: 36040107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA Extraction Method Impacts Quality Metrics and Sequencing Results in Formalin-Fixed, Paraffin-Embedded Tissue Samples.
    Decruyenaere P; Verniers K; Poma-Soto F; Van Dorpe J; Offner F; Vandesompele J
    Lab Invest; 2023 Feb; 103(2):100027. PubMed ID: 37039153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical Characteristics and Prognosis of 56 Lymphoma Patients with Mediastinal Masses].
    Yu H; Wang L; Zhu HY; Wu W; Liang JH; Yin H; Fan L; Li JY; Xu W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):495-499. PubMed ID: 32319385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Subtyping of Diffuse Large B-Cell Lymphoma Using a Novel Quantitative RT-PCR Assay.
    Ta R; Santini C; Gou P; Lee G; Tai YC; O'Brien C; Fontecha M; Grant C; Bacon L; Finn S; Vandenberghe E; Quinn F; Dua R; Flavin R
    J Mol Diagn; 2021 Mar; 23(3):323-340. PubMed ID: 33385586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducible, Quantitative, and Flexible Molecular Subtyping of Clinical DLBCL Samples Using the NanoString nCounter System.
    Veldman-Jones MH; Lai Z; Wappett M; Harbron CG; Barrett JC; Harrington EA; Thress KS
    Clin Cancer Res; 2015 May; 21(10):2367-78. PubMed ID: 25301847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Mediastinal B-Cell Lymphoma in Children and Young Adults.
    Forlenza CJ; Chadburn A; Giulino-Roth L
    J Natl Compr Canc Netw; 2023 Mar; 21(3):323-330. PubMed ID: 36898366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse large B-cell lymphoma: sub-classification by massive parallel quantitative RT-PCR.
    Xue X; Zeng N; Gao Z; Du MQ
    Lab Invest; 2015 Jan; 95(1):113-20. PubMed ID: 25418578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of PD-L1 detection assays and corresponding significance in evaluation of diffuse large B-cell lymphoma.
    Huang S; Nong L; Liang L; Zheng Y; Wang W; Liu J; Li D; Li X; Wang Y; Zhang B; Li T
    Cancer Med; 2019 Jul; 8(8):3831-3845. PubMed ID: 31150165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microarray gene expression analysis of fixed archival tissue permits molecular classification and identification of potential therapeutic targets in diffuse large B-cell lymphoma.
    Linton K; Howarth C; Wappett M; Newton G; Lachel C; Iqbal J; Pepper S; Byers R; Chan WJ; Radford J
    J Mol Diagn; 2012; 14(3):223-32. PubMed ID: 22446084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up.
    Zhou H; Xu-Monette ZY; Xiao L; Strati P; Hagemeister FB; He Y; Chen H; Li Y; Manyam GC; Li Y; Montes-Moreno S; Piris MA; Young KH
    Blood Cancer J; 2020 May; 10(5):49. PubMed ID: 32366834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating RNA biomarkers in diffuse large B-cell lymphoma: a systematic review.
    Decruyenaere P; Offner F; Vandesompele J
    Exp Hematol Oncol; 2021 Feb; 10(1):13. PubMed ID: 33593440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens.
    Mottok A; Wright G; Rosenwald A; Ott G; Ramsower C; Campo E; Braziel RM; Delabie J; Weisenburger DD; Song JY; Chan WC; Cook JR; Fu K; Greiner T; Smeland E; Holte H; Savage KJ; Glinsmann-Gibson BJ; Gascoyne RD; Staudt LM; Jaffe ES; Connors JM; Scott DW; Steidl C; Rimsza LM
    Blood; 2018 Nov; 132(22):2401-2405. PubMed ID: 30257882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative nuclease protection assay in paraffin-embedded tissue replicates prognostic microarray gene expression in diffuse large-B-cell lymphoma.
    Roberts RA; Sabalos CM; LeBlanc ML; Martel RR; Frutiger YM; Unger JM; Botros IW; Rounseville MP; Seligmann BE; Miller TP; Grogan TM; Rimsza LM
    Lab Invest; 2007 Oct; 87(10):979-97. PubMed ID: 17700562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study.
    Rieger M; Österborg A; Pettengell R; White D; Gill D; Walewski J; Kuhnt E; Loeffler M; Pfreundschuh M; Ho AD;
    Ann Oncol; 2011 Mar; 22(3):664-670. PubMed ID: 20724576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptome sequencing of archived lymphoma specimens is feasible and clinically relevant using exome capture technology.
    Skaftason A; Qu Y; Abdulla M; Nordlund J; Berglund M; Ednersson SB; Andersson PO; Enblad G; Amini RM; Rosenquist R; Mansouri L
    Genes Chromosomes Cancer; 2022 Jan; 61(1):27-36. PubMed ID: 34647650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary mediastinal large B-cell lymphoma.
    Savage KJ
    Blood; 2022 Sep; 140(9):955-970. PubMed ID: 34496020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.